Aa
A
A
Close
1707536 tn?1334977677
BMS 78% SVR12 1b Prior Null Responders
"Investigational Hepatitis C Dual DAA Regimen of Daclatasvir and Asunaprevir Achieved SVR12 in 78% of Difficult-to-Treat Genotype 1b Prior Null Responders In Expanded Phase II Study"



http://finance.yahoo.com/news/investigational-hepatitis-c-dual-daa-214500427.html
Cancel
0 Answers
Page 1 of 1
Your Answer
Avatar universal
Answer
Know how to answer? Tap here to leave your answer...
Answer
Submit Answer
A
A
Recent Activity
1420486 tn?1384796753
Blank
blondie717 joined this community
Welcome them!
19 hrs ago
517872 tn?1465669131
Blank
senseanonymous  commented on photo
22 hrs ago
707563 tn?1455827280
Blank
Emily_MHModerator Survey link - https://goo.g... Comment
Jun 26
Blank
Weight Tracker
Track your weight over time
Start Tracking Now
Top Hepatitis Answerers
446474 tn?1446351282
Blank
San Francisco, CA
Avatar universal
Blank
163305 tn?1333672171
Blank
Rural Mural, CA
1815939 tn?1377995399
Blank
317787 tn?1465993311
Blank
DC
Avatar universal
Blank
Hepatitis C Community Resources
RSS Expert Activity
233488 tn?1310696703
Blank
Marathon Running Done Over Many Yea...
05/15 by John C Hagan III, MD, FACS, FAAOBlank
233488 tn?1310696703
Blank
New Article on Multifocal IOL vs &q...
05/15 by John C Hagan III, MD, FACS, FAAOBlank
748543 tn?1463449675
Blank
TMJ/TMJ The Connection Between Teet...
01/15 by Hamidreza Nassery , DMD, FICOI, FAGD, FICCMOBlank
Top Hepatitis Answerers
446474 tn?1446351282
Blank
San Francisco, CA
Avatar universal
Blank
163305 tn?1333672171
Blank
Rural Mural, CA
1815939 tn?1377995399
Blank
317787 tn?1465993311
Blank
DC
Avatar universal
Blank